EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk

María Anguita-Gámez, David Vivas, Raquel Ferrandis, María Asunción Esteve-Pastor, Rafael González-Manzanares, Marysol Echeverri, Jesús Igualada, Isabel Egocheaga, Beatriz Nozal-Mateo, Ane Abad-Motos, Elena Figuero, Nuria Bouzó-Molina und 12 weitere

Revista Española de Cardiología (English Edition) · 2025

DOI: 10.1016/j.rec.2024.09.010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2025. Verfasst von María Anguita-Gámez und 23 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain. Electronic address: maria.anguita95@gmail.com. Hauptthemen laut MEDLINE: Fibrinolytic Agents, Hemorrhage, Registries, Myocardial Ischemia. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Scottish Environment Protection Agency, University of Bristol, Johnson and Johnson.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: To analyze the clinical impact of the inappropriate use of antithrombotic treatment in patients with high ischemic or hemorrhagic risk during the periprocedural/perisurgical period in Spain. METHODS: Prospective multicenter observational registry of patients receiving antiplatelet and/or anticoagulant therapy who required an intervention. The incidence of 30-day events was compared based on the peri-intervention management of antithrombotic treatment and the patients' risk classification (high vs. moderate-to-low risk). The primary endpoint was a composite of death, cardiovascular ischemic events, or bleeding events classified as BARC 2 or higher. RESULTS: A total of 1152 patients were analyzed. Of these, 1.9% had both high ischemic and hemorrhagic risks (A);10.8% had high ischemic risk and low-to-moderate hemorrhagic risk (B); 12% had high hemorrhagic risk and low-to-moderate ischemic risk (C); and 75.3% had both low-to-moderate risks (D). The prevalence of inappropriate treatment was higher in the subgroup with high hemorrhagic risk and low-to-moderate ischemic risk (C) (62.6% vs 40.9% in subgroup A; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibrinolytic AgentsHemorrhageRegistriesMyocardial IschemiaGuideline AdherenceHumansMaleFemaleProspective StudiesAgedSpainPrognosisRisk FactorsIncidenceRisk AssessmentMiddle AgedFollow-Up Studies

Stichwörter der Autor:innen

Abordaje perioperatorioAntiagregantes plaquetariosAnticoagulantesAnticoagulantsAntiplateletsPerioperative managementPrognosisPronósticoRiesgoRisk

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain. Electronic address: maria.anguita95@gmail.com.
  • Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain; Departamento de Medicina, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
  • Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, El Palmar, Murcia, Spain; Centro de Investigación B…
  • Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Hospital Universitario Reina Sofía, Instituto Maimónides para la Investigación Biomédica de Córdoba (I…
  • Medicina de Familia, Centro de Salud Isla de Oza, Madrid, Spain.

Förderung

  • Scottish Environment Protection Agency
  • University of Bristol
  • Johnson and Johnson
  • British Society of Periodontology and Implant Dentistry

Zitieren

APA

Anguita-Gámez, M., Vivas, D., Ferrandis, R., Esteve-Pastor, M. A., González-Manzanares, R., Echeverri, M., Igualada, J., Egocheaga, I., Nozal-Mateo, B., Abad-Motos, A., Figuero, E., Bouzó-Molina, N., Lozano, T., Álvarez-Ortega, C., Torres, J., Descalzo, M. J., Catalá, J. C., Martín-Rioboo, E., Moliner, A., …, & REQXAA study researchers (2025). Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2024.09.010

Vancouver

Anguita-Gámez M, Vivas D, Ferrandis R, Esteve-Pastor MA, González-Manzanares R, Echeverri M, et al. Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk. Revista Española de Cardiología (English Edition). 2025. doi:10.1016/j.rec.2024.09.010

BibTeX
@article{AnguitaGmez2025,
  author = {Anguita-Gámez, María and Vivas, David and Ferrandis, Raquel and Esteve-Pastor, María Asunción and González-Manzanares, Rafael and Echeverri, Marysol and Igualada, Jesús and Egocheaga, Isabel and Nozal-Mateo, Beatriz and Abad-Motos, Ane and Figuero, Elena and Bouzó-Molina, Nuria and Lozano, Teresa and Álvarez-Ortega, Carlos and Torres, Javier and Descalzo, María José and Catalá, Juan Carlos and Martín-Rioboo, Enrique and Moliner, Alejandra and Rodríguez-Contreras, Rocío and Carnero-Alcázar, Manuel and Marín, Francisco and Anguita, Manuel and REQXAA study researchers, REQXAA study researchers},
  title = {Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2025},
  doi = {10.1016/j.rec.2024.09.010}
}
Kostenlos starten →